Tomáš Šimurda/LinkedIn
Jun 16, 2026, 13:49
Tomáš Šimurda: Fibromics Team Secures EHA Innovation Grant for Innovative Research
Tomáš Šimurda, Hematologist at National Center of Hemostasis and Thrombosis, University Lecturer at Jessenius Faculty of Medicine in Martin, shared a post on LinkedIn:
“Honored to receive the 2026 European Hematology Association (EHA) Innovation Grant.
This recognition reflects the strength of international collaboration within the Fibromics consortia together with Alessandro Casini, Giancarlo Castaman, Saskia Schols, and Maartje van den Biggelaar.
Grateful to EHA for supporting innovative research in hematology and to all colleagues and collaborators who contribute to this journey.”
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award
-
Sep 24, 2026, 18:42Titilope Fasipe: Proud to Support American Society of Hematology’s SCD Initiative
-
Sep 24, 2026, 18:34Ifeanyichukwu Ifechidere: Why Coagulation Samples Can Be “Too Valuable to Throw Away”?
-
Sep 24, 2026, 18:33Aswin K. Mohan: When a Superpower Hears the Call for Blood
-
Sep 24, 2026, 18:31Mercy Lung’aho: Anemia Is Not Only An Iron Problem
-
Sep 24, 2026, 18:29Nick Hanson: Before a Dementia Diagnosis Check Vitamin B12
-
Sep 24, 2026, 18:28Rachel McBryan: Nearly One in Five Older Canadians Has Low Vitamin B12
-
Sep 24, 2026, 18:27Kemal Karaagac: Early DOAC Initiation After Acute Ischaemic Stroke in Atrial Fibrillation
-
Sep 24, 2026, 18:26Mohammed A. AlOmar: What Characterizes Young Stroke in the UAE?